| Natalia Arana, | |
|
1500 E Medical Center Dr, Ann Arbor, MI 48109-5000 | |
| (734) 936-4000 | |
| Not Available |
| Full Name | Natalia Arana |
|---|---|
| Gender | Female |
| Speciality | Hospitalist |
| Experience | 7 Years |
| Location | 1500 E Medical Center Dr, Ann Arbor, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730610528 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 4301502036 (Michigan) | Secondary |
| 207R00000X | Internal Medicine | 4301502036 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Michigan Health System | Ann arbor, MI | Hospital |
| St Joseph Mercy Chelsea | Chelsea, MI | Hospital |
| St Joseph Mercy Hospital | Ann arbor, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Chelsea Community Hospital | 0648171074 | 112 |
| Iha Health Services Corporation | 2466351440 | 911 |
| Regents Of The University Of Michigan | 3779496856 | 2953 |
News Archive
The Military Order of the Purple Heart is stepping up to the call from Congress for input on how best to resolve the issues most important to the nation's veterans. America's wounded warriors from across the country will converge on Washington, D.C. during 8-12 February, 2010 to meet with their state's Senators and Representatives to educate them on these important issues
Oxygen Biotherapeutics, Inc. reported today that the Data Safety Monitoring Board overseeing the company's ongoing Phase II-b trial has, based on the results of the first cohort of patients, authorized the company to move forward with the next cohort of the study. This trial is a randomized, single-dose, placebo-controlled, double-blind, dose-escalation study to evaluate the safety and tolerability of our Oxycyte® emulsion in patients with severe non-penetrating traumatic brain injury.
"Artemisinin, a crucial drug in the global fight against malaria, could soon become cheaper and easier to make, thanks to researchers who have found a better way to synthesize the compound," Science NOW reports, providing an overview of the research published in Angewandte Chemie on Monday.
DSS Research, the leader in market research for the health insurance industry, developed a proprietary set of metrics that gauge the level of engagement in health care on the part of the consumer. This quarter we added extra questions to further test the relationship between different literacy measures and the level of engagement amongst commercial and Medicare populations and the uninsured.
The Bristol-Myers Squibb Foundation today announced Together on Diabetes: Communities Uniting to Meet America's Diabetes Challenge, a 5-year, $100 million initiative to help patients living with type 2 diabetes better manage their disease beyond the doors of their doctor's office in their homes and communities and for the course of their disease.
› Verified 4 days ago
| Entity Name | Regents Of The University Of Michigan |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205868353 PECOS PAC ID: 3779496856 Enrollment ID: O20031106000325 |
News Archive
The Military Order of the Purple Heart is stepping up to the call from Congress for input on how best to resolve the issues most important to the nation's veterans. America's wounded warriors from across the country will converge on Washington, D.C. during 8-12 February, 2010 to meet with their state's Senators and Representatives to educate them on these important issues
Oxygen Biotherapeutics, Inc. reported today that the Data Safety Monitoring Board overseeing the company's ongoing Phase II-b trial has, based on the results of the first cohort of patients, authorized the company to move forward with the next cohort of the study. This trial is a randomized, single-dose, placebo-controlled, double-blind, dose-escalation study to evaluate the safety and tolerability of our Oxycyte® emulsion in patients with severe non-penetrating traumatic brain injury.
"Artemisinin, a crucial drug in the global fight against malaria, could soon become cheaper and easier to make, thanks to researchers who have found a better way to synthesize the compound," Science NOW reports, providing an overview of the research published in Angewandte Chemie on Monday.
DSS Research, the leader in market research for the health insurance industry, developed a proprietary set of metrics that gauge the level of engagement in health care on the part of the consumer. This quarter we added extra questions to further test the relationship between different literacy measures and the level of engagement amongst commercial and Medicare populations and the uninsured.
The Bristol-Myers Squibb Foundation today announced Together on Diabetes: Communities Uniting to Meet America's Diabetes Challenge, a 5-year, $100 million initiative to help patients living with type 2 diabetes better manage their disease beyond the doors of their doctor's office in their homes and communities and for the course of their disease.
› Verified 4 days ago
| Entity Name | Iha Health Services Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457408965 PECOS PAC ID: 2466351440 Enrollment ID: O20040108000355 |
News Archive
The Military Order of the Purple Heart is stepping up to the call from Congress for input on how best to resolve the issues most important to the nation's veterans. America's wounded warriors from across the country will converge on Washington, D.C. during 8-12 February, 2010 to meet with their state's Senators and Representatives to educate them on these important issues
Oxygen Biotherapeutics, Inc. reported today that the Data Safety Monitoring Board overseeing the company's ongoing Phase II-b trial has, based on the results of the first cohort of patients, authorized the company to move forward with the next cohort of the study. This trial is a randomized, single-dose, placebo-controlled, double-blind, dose-escalation study to evaluate the safety and tolerability of our Oxycyte® emulsion in patients with severe non-penetrating traumatic brain injury.
"Artemisinin, a crucial drug in the global fight against malaria, could soon become cheaper and easier to make, thanks to researchers who have found a better way to synthesize the compound," Science NOW reports, providing an overview of the research published in Angewandte Chemie on Monday.
DSS Research, the leader in market research for the health insurance industry, developed a proprietary set of metrics that gauge the level of engagement in health care on the part of the consumer. This quarter we added extra questions to further test the relationship between different literacy measures and the level of engagement amongst commercial and Medicare populations and the uninsured.
The Bristol-Myers Squibb Foundation today announced Together on Diabetes: Communities Uniting to Meet America's Diabetes Challenge, a 5-year, $100 million initiative to help patients living with type 2 diabetes better manage their disease beyond the doors of their doctor's office in their homes and communities and for the course of their disease.
› Verified 4 days ago
| Entity Name | Chelsea Community Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912947409 PECOS PAC ID: 0648171074 Enrollment ID: O20040119000004 |
News Archive
The Military Order of the Purple Heart is stepping up to the call from Congress for input on how best to resolve the issues most important to the nation's veterans. America's wounded warriors from across the country will converge on Washington, D.C. during 8-12 February, 2010 to meet with their state's Senators and Representatives to educate them on these important issues
Oxygen Biotherapeutics, Inc. reported today that the Data Safety Monitoring Board overseeing the company's ongoing Phase II-b trial has, based on the results of the first cohort of patients, authorized the company to move forward with the next cohort of the study. This trial is a randomized, single-dose, placebo-controlled, double-blind, dose-escalation study to evaluate the safety and tolerability of our Oxycyte® emulsion in patients with severe non-penetrating traumatic brain injury.
"Artemisinin, a crucial drug in the global fight against malaria, could soon become cheaper and easier to make, thanks to researchers who have found a better way to synthesize the compound," Science NOW reports, providing an overview of the research published in Angewandte Chemie on Monday.
DSS Research, the leader in market research for the health insurance industry, developed a proprietary set of metrics that gauge the level of engagement in health care on the part of the consumer. This quarter we added extra questions to further test the relationship between different literacy measures and the level of engagement amongst commercial and Medicare populations and the uninsured.
The Bristol-Myers Squibb Foundation today announced Together on Diabetes: Communities Uniting to Meet America's Diabetes Challenge, a 5-year, $100 million initiative to help patients living with type 2 diabetes better manage their disease beyond the doors of their doctor's office in their homes and communities and for the course of their disease.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Natalia Arana, 3621 S State St, Ann Arbor, MI 48108-1633 Ph: (734) 647-5299 | Natalia Arana, 1500 E Medical Center Dr, Ann Arbor, MI 48109-5000 Ph: (734) 936-4000 |
News Archive
The Military Order of the Purple Heart is stepping up to the call from Congress for input on how best to resolve the issues most important to the nation's veterans. America's wounded warriors from across the country will converge on Washington, D.C. during 8-12 February, 2010 to meet with their state's Senators and Representatives to educate them on these important issues
Oxygen Biotherapeutics, Inc. reported today that the Data Safety Monitoring Board overseeing the company's ongoing Phase II-b trial has, based on the results of the first cohort of patients, authorized the company to move forward with the next cohort of the study. This trial is a randomized, single-dose, placebo-controlled, double-blind, dose-escalation study to evaluate the safety and tolerability of our Oxycyte® emulsion in patients with severe non-penetrating traumatic brain injury.
"Artemisinin, a crucial drug in the global fight against malaria, could soon become cheaper and easier to make, thanks to researchers who have found a better way to synthesize the compound," Science NOW reports, providing an overview of the research published in Angewandte Chemie on Monday.
DSS Research, the leader in market research for the health insurance industry, developed a proprietary set of metrics that gauge the level of engagement in health care on the part of the consumer. This quarter we added extra questions to further test the relationship between different literacy measures and the level of engagement amongst commercial and Medicare populations and the uninsured.
The Bristol-Myers Squibb Foundation today announced Together on Diabetes: Communities Uniting to Meet America's Diabetes Challenge, a 5-year, $100 million initiative to help patients living with type 2 diabetes better manage their disease beyond the doors of their doctor's office in their homes and communities and for the course of their disease.
› Verified 4 days ago
Nabil Alkhoury Fallouh, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1500 East Medical Center Dr, 3rd Floor Taubman Ctr Recp B, Ann Arbor, MI 48109 Phone: 734-936-5582 | |
Sameer Dev Saini, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Dr. David Alexander Stewart, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Dr, 12th Floor C.s. Mott Children's Hospital Room 525, Ann Arbor, MI 48109 Phone: 734-763-5302 Fax: 734-647-5624 | |
Dr. Aiman M Mahmood, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, Med Inn C728, Ann Arbor, MI 48109 Phone: 734-998-0891 | |
Anastasia Irene Wasylyshyn, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Katherine Saber Salisbury, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4260 Plymouth Rd, Ann Arbor, MI 48109 Phone: 734-764-6831 | |
Anne Lewis Carlton, Internal Medicine Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-647-5900 |